Neutrophils expressing CD66b, CD11b, PD-L1, and high levels of CD170 represent the pro-tumor subtype, whereas CD66+, CD11b+, CD170 low, and CD177+ neutrophils have an anti-tumor role (77, 78). This evidence concerns the gene CD177 and neoplasm.